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A Common Signaling Pathway Via Syk and Lyn Tyrosine Kinases Generated From
Capping of the Sialomucins CD34 and CD43 in Immature Hematopoietic Cells
By Jun-ichi Tada, Mitsuhiro Omine, Toshio Suda, and Naoto Yamaguchi
The sialomucin CD34 is a useful marker for hematopoietic
stem/progenitor cells. However, the role of CD34 remains
poorly understood. Here we investigate the functions of
CD34 and another sialomucin CD43 coexpressed on hemato-
poietic stem/progenitor cells. Stimulation of undifferenti-
ated hematopoietic KG1a cells with anti-CD34 or anti-CD43
induced homotypic cytoadhesion, accompanied by forma-
tion of a long-lived cap of CD34 and CD43 respectively, which
colocalized with F-actin. Stimulation with either antibody
specifically increased tyrosine phosphorylation of the identi-
cal set of proteins of Lyn, Syk, pp60, pp69, and pp77 at the
capping site. These events were similar to those observed in
monocytic U937 cells ectopically expressing CD34. After
stimulation of KG1a cells, coimmunoprecipitation of Lyn
with pp69 and pp77 and of Syk with pp37 was detected in
the membrane fraction. Blockade of antibody-induced cap
formation by treatment with cytochalasin D leads to inhibi-
tion of tyrosine phosphorylation of Syk and pp77 and homo-
typic cytoadhesion. Moreover, normal human CD341 bone
marrow cells showed cap formation of CD34 or CD43 after
stimulation. These results suggest that crosslinking of either
CD34 or CD43 activates the same signaling pathway for
cytoadhesion through Lyn, Syk, and the novel tyrosine-
phosphorylated proteins within hematopoiesis.
r 1999 by The American Society of Hematology.
P
ROTEIN-TYROSINE phosphorylation is critical in signal
transduction pathways by which extracellular ligands
induce proliferation, differentiation, and functional activation of
multiple cell types, including hematopoietic cells.1,2 Tyrosine
phosphorylation is mediated by either receptor-type protein-
tyrosine kinases, which possess extracellular domains that bind
ligands, or by nonreceptor-type protein-tyrosine kinases, which
appear to associate with receptor-type proteins directly or
indirectly.
CD34isaheavilyO-glycosylatedsialomucin-typetransmem-
brane glycoprotein that is selectively expressed on hematopoi-
etic stem/progenitor cells and vascular endothelial cells.3-5
Cloning of human and murine CD34 has shown that the protein
has no signiﬁcant sequence homology to other proteins in the
database. The cytoplasmic domain bears a consensus site for
tyrosine phosphorylation and two potential targeting sites for
protein kinase C, but lacks enzymatic domain motifs.6-8 A
truncated form of the protein with a shorter cytoplasmic domain
is produced by alternative splicing.9,10 The natural ligand or
counter-receptor for CD34 has not yet been found in the
hematopoietic milieu, whereas CD34 present on high endothe-
lial venules in lymph nodes can function as a ligand for the
lymphocyte-homing receptor L-selectin.11
Monoclonal antibodies (MoAbs) directed against CD34 are
useful for enrichment of hematopoietic progenitor cells from
bone marrow (BM) and umbilical cord blood and are useful in
analysis of ‘‘mobilized’’ hematopoietic progenitor cells in
leukemia, in BM transplantation, and in gene therapy.4,12
Despite the signiﬁcance of CD34 as a marker for hematopoietic
stem/progenitor cells, the function of CD34 during hematopoi-
esis is unclear. Recent studies on CD34 function thus far
indicate that engagement of particular determinants of CD34 by
MoAbs increases cell adhesion of CD34-expressing hematopoi-
etic cells,13-15 and that expression of CD34 inhibits terminal
differentiation of hematopoietic cells.16 It is hypothesized that
CD34 is involved in maintenance of a primitive hematopoietic
progenitor cell phenotype in BM stem cell niches.12-16
CD43 (leukosialin/sialophorin), whose glycosylation is aber-
rant in patients with Wiskott-Aldrich syndrome, is a major
transmembrane cell-surface sialomucin-type glycoprotein ex-
pressed on a variety of hematopoietic cells.17,18 CD43 is a
molecule mediating both adhesion and repulsion, the latter
through its negative charge and extended structure.17,19 Not only
does CD43 function in passive cell adhesion, but it actively
participates in signal transduction of hematopoietic cells, such
asTlymphocytes, monocytes, and natural killer cells.18There is
increasing evidence that signaling activated by stimulation with
anti-CD43 MoAbs involves tyrosine phosphorylation.20,21 In
addition, CD43 is reported to interact with actin ﬁlaments
through ezrin/radixin/moesin (ERM) family members, suggest-
ing that CD43 regulates cytoskeletal reorganization.22
Recent observations with speciﬁc inhibitors suggest that
tyrosine phosphorylation is involved in homotypic cell aggrega-
tion induced by crosslinking of CD34 upon stimulation with
anti-CD34 MoAbs.13,15 Both CD34 and CD43 are heavily
O-glycosylatedsialomucinswithanextendedrodlikeconforma-
tion, and they are coexpressed on hematopoietic stem/
progenitor cells.7,23-26 These similarities suggest that CD34 and
CD43 have overlapping or partially redundant functions as
signal transducers in hematopoietic cell adhesion.
In this study, we show that crosslinking of either CD34 or
CD43 with speciﬁc MoAbs induces an increase in tyrosine
phosphorylationofthesamesetofproteinsthroughnonreceptor-
typetyrosinekinasesSykandLynatthecappingsites.Thus,our
results provide the ﬁrst demonstration that both CD34 and
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tyrosine phosphorylation in cytoadhesion.
MATERIALS AND METHODS
Antibodies and reagents. Anti-CD34 (4A1, Nichirei,Tokyo, Japan;
My10 and 8G12, Becton Dickinson, San Jose, CA; QBEND10,
Immunotech S.A., Marseille, France), anti-CD43 (MEM59, Sanbio,Am
Uden, The Netherlands), anti-phosphotyrosine (4G10 and biotinylated
4G10, UBI, Lake Placid, NY), anti-Syk (4D10) and anti-Lyn (Lyn44)
(Santa Cruz Biotechnology, Santa Cruz, CA), anti-CD11a (G43-25B)
and anti-CD49e (IIA1) (PharMingen, San Diego, CA), CD18 (MEM48,
Southern Biotechnology Associates, Birmingham, AL), anti-CD49d
(BU49) and anti-CD54 (15.2) (Ancell Immunology Research Products,
Bayport, MN), and MOPC21 (control IgG1, Sigma, St Louis, MO) were
used. Horseradish peroxidase-F(ab8)2 fragments of anti-mouse Ig and of
anti-rabbit Ig (Amersham, Buckinghamshire, UK), goat anti-mouse IgG
Fcg fragment speciﬁc (Jackson Immunoresearch, West Grove, PA),
ﬂuorescein isothiocyanate (FITC)-F(ab8)2 fragment of anti-mouse IgG
and IgM (BioSource International, Camarillo, CA), FITC-avidin
(GIBCO-BRL, Grand Island, NY), and rhodamine-phalloidin (Molecu-
lar Probes, Eugene, OR) were used.
Cellcultureandﬂowcytometry. Thehumanundifferentiatedmyelo-
blastic leukemia cell line KG1a27 was cultured in RPMI 1640 medium
containing 10% fetal bovine serum (FBS). The human monocytic cell
line U93728 was cultured in Iscove’s modiﬁed Dulbecco’s medium
supplemented with 10% FBS. Cells were stained with My10, 4A1,
QBEND10, 8G12, MEM59, or MOPC21 (control IgG1), followed by an
FITC-F(ab8)2 fragment of anti-mouse Ig, and analyzed by a FACScan
(Becton Dickinson).
Preparation of normal CD341 BM cells. Light-density mono-
nuclear cells were separated from BM cells of a normal adult volunteer
by Lymphoprep (Nycomed Pharmaas Diagnostics, Oslo, Norway).
Cells were washed, resuspended at 1 3 108 cells/mL in phosphate-
buffered saline (PBS) containing 0.1% bovine serum albumin (BSA),
and incubated with 20 µg/mL anti-CD34 (8G12, class III) at 4°C for 30
minutes. After washing, cells were resuspended at 1 3 108 cells/mL
with MACS rat anti-mouse IgG1 microbeads (Miltenyi Biotec GmbH,
Bergisch Gladbach, Germany), and incubated at 4°C for 15 minutes.
CD341 cells were separated in magnetic ﬁeld of a MACS separator.
Plasmid transfection. cDNAs for the full-length human CD34
(kindly provided by Drs D.L. Simmons and B. Seed, Massachusetts
General Hospital, Boston, MA)7 and the truncated human CD34 (kindly
provided by Drs Y. Nakamura and H. Nakauchi, Institute of Basic
Medical Sciences, The University of Tsukuba, Tsukuba, Japan)10 were
cloned into the pBCMGSNeo vector.29 U937 cells were transfected by
electroporation with pBCMGSNeo vector alone or with pBCMGSNeo
vector containing full-length or truncated CD34. Stably transfected
clones were selected in 500 µg/mLG418.
Stimulation with MoAbs. Cells were adjusted to 1.25 3 107
cells/mL in phosphorylation medium (RPMI 1640 medium supple-
mented with 25 mmol/L HEPES, pH 7.2, 0.1% BSA, and 0.2 mmol/L
Na3VO4). Cells were incubated at 4°C with either anti-CD34, anti-
CD43, anti-CD11a, anti-CD18, anti-CD49d, anti-CD49e, anti-CD54 or
control IgG1 (MOPC21) (12.5 µg/mL) for 30 minutes. After incubation
with 25 µg/mL goat anti-mouse Ig antibody for an additional 30
minutes, the cells were stimulated for the indicated times at 37°C. In
blocking experiments, cells were preincubated in phosphorylation
medium without Na3VO4 at 37°C for 30 minutes with 10 µg/mL
cytochalasin D (Sigma) or 30 mmol/L NaF, and the cells were then
stimulated in the presence of 0.2 mmol/LNa3VO4 plus each inhibitor as
described above.
Immunoﬂuorescence. Cells (1.25 3 107 cells/mL) were stimulated
with various antibodies as described above. The cells were ﬁxed with
2.5% paraformaldehyde at room temperature for 30 minutes. After
washing, the cells were suspended in PBS containing 5% BSA for 30
minutes, and subsequently double-stained with FITC-anti-mouse Ig for
CD34, CD43, or other cell-surface molecules and rhodamine-phalloidin
for F-actin staining in PBS containing 3% BSA for 30 minutes. For
detection of tyrosine-phosphorylated proteins, cells were stimulated
with either anti-CD34 or anti-CD43, and ﬁxed as described above.After
being permeabilized in PBS containing 0.1% saponin, 5% BSA, and 5%
normal mouse serum as described previously,30 the cells were stained
with biotinylated 4G10 for 40 minutes, followed by FITC-avidin for 40
minutes.To avoid dephosphorylation, 10 mmol/LNa3VO4 was included
throughout the staining procedure. Confocal and Nomarski differential-
interference-contrast images were obtained using a Fluoview laser
scanning microscope (Olympus, Tokyo, Japan). Z-series sections were
recorded at 0.5- to 1-µm intervals and all sections were merged.
Western blotting and immunoprecipitation. Cells were washed with
HEPES-buffered saline (50 mmol/LHEPES, pH 7.4, 150 mmol/LNaCl,
and 1 mmol/L Na3VO4), and then lysed with Triton X-100 lysis buffer
(50 mmol/LHEPES, pH 7.4, 1%Triton X-100 [Sigma, St Louis, MO], 4
mmol/L EDTA, 100 mmol/L NaF, 2 mmol/L Na3VO4, and protease
inhibitors [50 µg/mL aprotinin, 200 µmol/L leupeptin, 50 µmol/L
pepstatin A, and 2 mmol/L phenylmethylsulfonyl ﬂuoride]). Lysates
were subjected to sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis(SDS-PAGE)andelectrotransferredontopolyvinylidenediﬂuo-
ride membranes. Immunodetection was performed by enhanced chemi-
luminescence, as described previously.31 Precleared lysates with
Pansorbin (Calbiochem, La Jolla, CA) were incubated at 4°C with
protein G-Sepharose beads (Pharmacia) precoated with the appropriate
MoAb. The immune complexes were analyzed, as described previ-
ously.31,32
Subcellularfractionation. Cellsweresuspendedinhypotonicbuffer
(10 mmol/L HEPES, pH 7.4, 10 mmol/L NaCl, 1 mmol/L KH2PO4,5
mmol/L NaHCO3, 5 mmol/L EDTA, 5 mmol/L EGTA, 0.2 mmol/L
Na3VO4, and protease inhibitors), freeze/thawed in liquid nitrogen, and
sonicated (6.25 W, 10 pulses for 2 seconds). After addition of an equal
volume of adjusting buffer (10 mmol/L HEPES, pH 7.4, 290 mmol/L
NaCl, 1 mmol/L KH2PO4, 5 mmol/L NaHCO3, 5 mmol/L EDTA, 5
mmol/L EGTA, 0.2 mmol/L Na3VO4, and protease inhibitors), the
lysate was centrifuged at 100,000g for 30 minutes, and the cytosol was
collected.The pellets were extracted in SDS-PAGE sample buffer or 1%
Triton X-100 lysis buffer.All steps were performed at 4°C.
Kinase assays. After washing immune complexes with modiﬁed
RIPA buffer (50 mmol/L HEPES, pH 7.4, 1% Triton X-100, 0.25%
SDS, 4 mmol/L EDTA, 2 mmol/L Na3VO4, and 2 mmol/L phenylmeth-
ylsulfonyl ﬂuoride) and Triton X-100 lysis buffer containing 2 mol/L
NaCl, an aliquot of each immunoprecipitate was subjected to an in vitro
kinase assay with 2.5 µmol/L [g-32P]ATP and an equal aliquot was
applied to a quantitative immunoblot, as described previously.31,32
Myelin basic protein (MBP) was used as an exogenous substrate for
Syk.33 The samples were separated on SDS-PAGE gels. The gels were
treated with 1N KOH at 56°C for 2 hours and subjected to a BAS 2000
BioImageAnalyzer (Fujix, Tokyo, Japan).
RESULTS
Tyrosine phosphorylation upon stimulation with anti-CD34.
To investigate CD34 signaling, we used three classes of
anti-CD34 MoAbs reacted to different epitopes on CD34: class
I MoAb (My10) binds to an epitope on sialylated oligosaccha-
ride chains extended from the CD34 core polypeptide; class II
MoAb (4A1 and QBEND10) to an epitope on asialo-oligosaccha-
ride chains also extended from the core polypeptide; and class
III MoAb (8G12) to an epitope present in the core polypep-
tide.34-38 Fluorescence-activated cell sorter (FACS) analysis
with the CD341 hematopoietic cell line KG1a showed that there
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stained with respective MoAbs (Fig 1A, b through e).
KG1a cells were stimulated with anti-CD34 MoAbs and
analyzed by Western blotting using the anti-phosphotyrosine
MoAb 4G10 (anti-pTyr). We found that addition of either
My10, 4A1, or QBEND10 increased tyrosine phosphorylation
of several proteins (Fig 1B, lanes 2 through 4). Prominent
tyrosine-phosphorylated proteins were detected at 60, 69, 72,
and 77 kD, and a small increase in tyrosine phosphorylation was
observed at 53 and 56 kD. However, addition of 8G12 did not
increase tyrosine phosphorylation nor did the control MoAb
MOPC21 (lanes 1 and 5). These results indicate that crosslink-
ing of CD34 via the particular determinants recognized by class
I or class II MoAbs increases tyrosine phosphorylation of
cellular proteins, suggesting that the signaling via CD34
involves tyrosine phosphorylation.
To examine the role of the cytoplasmic portion of CD34, we
generated stable clones of the human monocytic cell line U937
transfected with vector alone, with full-length CD34 having a
cytoplasmic domain containing possible sites of phosphoryla-
tion (Fig 2A; CD34full), or with the alternatively spliced form
withashortercytoplasmicportionlackingthesesites(CD34trunc).
FACS analysis and Western blotting showed similar expression
of CD34full and CD34trunc (Fig 2B and C). The level of their
expression in established clones (Fig 2B) was less than one
tenth that of endogenous CD34 in KG1a cells (Fig 1A).
Crosslinking of CD34trunc and CD34full increased tyrosine
phosphorylation of proteins of 53, 56, 60, 69, 72, and 77 kD
(Fig 2D), as seen in KG1a cells (Fig 1B). These increases were
moderate, probably due to lower expression of CD34full and
CD34trunc. By contrast, addition of 4A1 did not increase tyrosine
phosphorylation of cellular proteins in vector-transfected U937
cells (Fig 2D, left panel). These results suggest that the
observed increase in tyrosine phosphorylation is independent of
possible sites of phosphorylation in the cytoplasmic portion of
CD34.
Tyrosine phosphorylation upon stimulation with anti-CD43.
Both CD34 and CD43 are sialomucins expressed on hematopoi-
etic stem cells.7,12,23,25,26 We found with FACS analysis and
Western blotting that CD34 and CD43 were coexpressed on
KG1a cells (Fig 3A) and detected at 110 kD and 120 kD,
respectively (Fig 3B).
Because the anti-CD43 MoAb MEM59, which reacts to a
CD43-speciﬁc epitope on sialylated oligosaccharide chains
extended from the CD43 core polypeptide, corresponds to class
I anti-CD34 MoAbs in the characteristics of the epitope,26 we
investigated whether crosslinking of CD43 also induced tyro-
sine phosphorylation. KG1a cells were stimulated with either
4A1 or MEM59 and analyzed by Western blotting for phospho-
tyrosine. Intriguingly, stimulation with MEM59 was found to
increase tyrosine phosphorylation of proteins at 53, 56, 60, 69,
72, and 77 kD, with a proﬁle identical to that observed and
kinetics similar to those seen upon stimulation with 4A1 (class
II Ab to CD34) (Fig 3C). The increase was apparent 5 minutes
after stimulation, peaked at <30 minutes after stimulation, and
then gradually decreased until 6 hours after stimulation. In
addition, similar kinetics were observed upon stimulation with
My10 (class I MoAb to CD34) (data not shown). These results
indicate that stimulation with either anti-CD34 or anti-CD43
increases tyrosine phosphorylation of the same set of cellular
proteins.
Capping of CD34 or CD43 upon stimulation. To examine
the effect of stimulation with anti-CD34 on distribution of
CD34, immunoﬂuorescence microscopy studies were per-
formed. After 5 minutes of stimulation with My10, 4A1, or
QBEND10, KG1a cells became polarized with a spherical
projection and displayed colocalization of CD34 with F-actin
on the projection (Fig 4, d through l). Noticeably, only one large
cap was formed on each cell and that cap resembled a cellular
uropod, a kind of membrane protrusion. However, cells that
reacted with 8G12 showed uniform distributions of CD34 and
F-actin without the shape changes (Fig 4, m through o), as
observed in control cells (a through c). Cap formation of CD34
was temperature-dependent and the CD34 caps were not
internalized but stable on the cell surface at least 2 days after
stimulation (data not shown). Furthermore, after stimulation
with 4A1, CD34full-o rC D 3 4 trunc-expressing U937 cells dis-
played caps of the respective CD34 species colocalized with
Fig 1. Induction of tyrosine phosphorylation after
stimulation with anti-CD34 MoAbs. (A) FACS analy-
sis of KG1a cells stained with the anti-CD34 MoAbs
used in this study. Cells were stained with MOPC21
(a, control IgG), My10 (b, class I MoAb), 4A1 (c, class
II MoAb), QBEND10 (d, class II MoAb), and 8G12 (e,
class III MoAb). Solid lines represent staining with
specific antibodies, and dotted lines represent stain-
ing with the secondary reagent alone. (B) Western
blot of equal amounts of Triton X-100 lysates from
KG1a cells stimulated for 30 minutes with anti-CD34
MoAbs (lanes 2 through 5) or MOPC21 as a control
(lane 1) as described in Materials and Methods,
probed with anti-pTyr (4G10, top), and reprobed
with anti-CD34 (4A1, bottom). Molecular size mark-
ers are indicated on the left (kD).
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equivalent increases in tyrosine phosphorylation in cells stably
transfected with either construct (Fig 2D).
Next we examined whether capping was induced by stimula-
tion with anti-CD43. Similarly, addition of MEM59 induced
formation of uropod-like caps of CD43 on KG1a cells (Fig 4, s
through u). Cap formation of CD43, as well as CD34, was
almost complete 5 to 10 minutes after stimulation, and CD43
caps, like CD34 caps, were colocalized with F-actin (Fig 4,
compare panel u with panels f, i, and l). However, CD43 cap
formation did not affect the uniform distribution of CD34, and
vice versa (data not shown).
Furthermore, to test the ability of normal cells to form caps of
CD34 and CD43, we enriched CD341 cells from normal human
BM cells by MACS. As shown in Fig 6, stimulation with
anti-CD34 (4A1) or anti-CD43 (MEM59) induced cap forma-
tion on normal CD341 cells. However, cap formation of CD34
appeared incomplete, such as large clustering of CD34, prob-
ably because the level of CD34 expression in normal CD341
cells was lower than that detected in KG1a cells and U937 cells
ectopically expressing CD34. These results indicate that normal
CD341 cells are able to become polarized after crosslinking of
CD34 or CD43.
To exclude the possibility that the other adhesion molecules
similarly induce an increase in tyrosine phosphorylation, we
stimulated KG1a cells with a variety of MoAbs against the
integrins a4 (CD49d), a5 (CD49e), aL (CD11a), and b2
(CD18), and the intercellular adhesion molecule ICAM-1
(CD54). No increase in tyrosine phosphorylation of proteins at
53, 56, 60, 69, 72, and 77 kD was induced by these stimulations
(Fig 7A), although stimulation with anti-CD11a, anti-CD18,
anti-CD49d, anti-CD49e, or anti-CD54 induced cap/patch for-
mation of the respective molecules (Fig 7B). These results
indicate that stimulation with either anti-CD34 or anti-CD43
speciﬁcally induces not only cell polarization (capping/uropod
formation), but also an increase in tyrosine phosphorylation of
the same set of cellular proteins.
A complex of tyrosine-phosphorylated proteins. To exam-
ine the intracellular localization of tyrosine-phosphorylated
proteins upon crosslinking of CD34 or CD43, KG1a cells were
stimulated for 30 minutes, permeabilized, and stained for
phosphotyrosine. Figure 8 shows that after stimulation with
anti-CD34 (4A1, panels e through h) or anti-CD43 (MEM59,
panels i through l), capping of tyrosine-phosphorylated proteins
occurred in the projection colocalized with F-actin. These
results indicate that both CD34 and CD43 are capable of
forming caps accompanied by colocalization of both F-actin
andtyrosine-phosphorylatedproteins,suggestingthatcapforma-
Fig 2. Role of the cytoplasmic portion of CD34 in
tyrosine phosphorylation. (A) Amino acid sequence
of the cytoplasmic portions of the full-length CD34
(CD34full; top) and the truncated CD34 (CD34trunc;
bottom). Vertical bars indicate conserved residues.
PTK, a candidate tyrosine phosphorylation site; PKC,
a consensus phosphorylation site for protein kinase
C. (B) FACS analysis of U937 cells stably transfected
with vector alone, CD34full, or CD34trunc. Cells were
stained with anti-CD34 (4A1, solid lines) or with the
secondary reagent alone (dotted lines). (C) Western
blot of Triton X-100 lysates from U937 cells stably
transfected with Vector alone (lane 1), CD34full (lane
2), or CD34trunc (lane 3), probed with anti-CD34 (4A1).
(D) Western blots of equal amounts of Triton X-100
lysates from U937 cells stably transfected with vec-
tor, CD34full, or CD34trunc, probed with anti-pTyr
(4G10). Cells were stimulated for 30 minutes with
anti-CD34 (4A1) or MOPC21 (control) as described in
the legend to Fig 1. Molecular size markers are
indicated on the left (kD).
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capping sites.
To further characterize the tyrosine-phosphorylated proteins
pp53, pp56, pp60, pp69, pp72, and pp77 (Figs 1B, 2D, 3C, and
7A), we performed Western blotting and immunoprecipitation
with anti-CD34, anti-CD43, anti-Lyn, anti-Syk, anti-Src, anti-
paxillin, anti-HS1, or anti-phosphatidylinositol 3-kinase p85
subunit (PI3-kinase p85). CD34 and CD43 per se were not
tyrosine-phosphorylatedafteranystimulation,andneitherCD34
nor CD43 associated with pp53, pp56, pp60, pp69, pp72, and
pp77 in Triton X-100 lysates or digitonin lysates (data not
shown). Figure 9A shows that pp53/56 was identiﬁed as the
nonreceptor-type Src family kinase Lyn. Intriguingly, pp69 and
pp77 were coimmunoprecipitated with Lyn from Triton X-100
lysates. When KG1a cells were stimulated with anti-CD34
(4A1) or anti-CD43 (MEM59), tyrosine phosphorylation of
pp69 and pp77 coimmunoprecipitated with Lyn was greatly
enhanced, although an increase in tyrosine phosphorylation of
Lyn was barely detected (Fig 9A, compare lanes 2 and 3 with
lane 1). Immune complexes with Lyn did not contain CD34,
CD43, Syk, c-Src, paxillin, HS1, and PI3-kinase p85 (data not
shown). These results suggest that CD34 and CD43 are
functionally linked to Lyn because CD34 and CD43 can
enhance tyrosine phosphorylation of pp69 and pp77 associated
with Lyn.
Furthermore, pp72 was identiﬁed as the nonreceptor-type
tyrosine kinase Syk (Fig 9B). Stimulation of KG1a cells with
anti-CD34 (4A1) or anti-CD43 (MEM59) induced an increase
in tyrosine phosphorylation of Syk and the tyrosine-phosphory-
lated protein pp37 coimmunoprecipitated with Syk (lanes 2 and
3). The levels of tyrosine phosphorylation of Syk corresponded
to those of Syk-associated pp37. Immune complexes with Syk
did not contain CD34, CD43, Lyn, c-Src, paxillin, HS1,
PI3-kinase p85, p44/p42 MAP kinases, and p38 MAP kinase
(data not shown).
To determine whether different phosphorylation states of Syk
affected its kinase activity, Syk was separated from pp37 under
strong washing conditions and subjected to in vitro kinase
assays with MBPas substrate.As shown in Fig 9C, puriﬁed Syk
exhibited both high autophosphorylation and high tyrosine
phosphorylation of MBP (lane 1). However, increases in
tyrosine phosphorylation of Syk did not affect tyrosine kinase
activity of Syk (lanes 1 through 3). These results suggest that
CD34 and CD43 are capable of inducing an increase in tyrosine
phosphorylation of Syk leading to an increase in tyrosine
phosphorylation of pp37 associated with Syk.
Colocalization of CD34, CD43, Lyn, and Syk to membranes.
The cytoplasmic tyrosine kinase Lyn is anchored to the plasma
membrane via lipid moieties attached to its N-terminal. To
examine whether Syk, another cytoplasmic tyrosine kinase,
localized to the membrane fraction, subcellular fractionation
was performed by isolating the particulate fraction (P100),
which contained cellular membranes, and the cytosolic fraction
(S100). CD34, CD43, and Lyn were localized to the P100
fraction regardless of stimulation (Fig 10A, bottom panels,
lanes 2, 4, and 6). pp69 and pp77, as well as Lyn, were clearly
Fig 3. Coexpression of CD34 and CD43 on KG1a
cells and stimulation with MoAbs to CD34 or CD43.
(A) FACS analysis of KG1a cells stained with anti-
CD34 (4A1) or anti-CD43 (MEM59). Solid lines repre-
sent staining with specific antibodies, and dotted
lines represent staining with the secondary reagent
alone. (B) Western blots of Triton X-100 lysates from
KG1a cells, probed with anti-CD34 (4A1, lane 1) or
anti-CD43 (MEM59, lane 2). (C) Western blots of
equal amounts of Triton X-100 lysates from KG1a
cellsstimulatedwithanti-CD34(4A1,lanes2through
7), anti-CD43 (MEM59, lanes 9 through 14) for the
indicated times or incubated with MOPC21 (control
IgG, lanes 1 and 8) for 30 minutes at 37°C, probed
with anti-pTyr (4G10). Molecular size markers are
indicated on the left (kD).
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indicating that a complex of Lyn with pp69 and pp77 is formed
at the plasma membrane after stimulation. A large fraction of
Syk was present in the S100 fraction, and became tyrosine-
phosphorylated after stimulation (top panels, lanes 1, 3, and 5).
A small fraction of Syk was, in particular, constitutively
localized to the P100 fraction (the second lowest panel, lanes 2,
4, and 6), and tyrosine phosphorylation of membrane-bound
Syk was also induced (top panel).The proportion of membrane-
bound Syk to cytosolic Syk was unchanged after stimulation,
suggesting that cytosolic Syk is not translocated to membranes
during stimulation. In addition, pp60 was distributed to cyto-
solic and membrane fractions, and stimulation with anti-CD34
(4A1) or anti-CD43 (MEM59) increased tyrosine phosphoryla-
tion of pp60 present in both fractions (top panel).
To examine the role of membrane-bound Syk, cytosolic and
membrane-bound Syk were immunoprecipitated. Stimulation
with anti-CD34 (4A1) or anti-CD43 (MEM59) greatly in-
creased tyrosine phosphorylation of both cytosolic and mem-
brane-bound Syk (Fig 10B, top panel, compare lanes 3 through
6 with lanes 1 and 2), whereas levels of Syk were generally
comparable (bottom panel). The levels of tyrosine phosphoryla-
tion of membrane-bound Syk were more than threefold higher
than those of cytosolic Syk (top panel, lanes 3 through 6). Only
membrane-bound Syk was coimmunoprecipitated with pp37
(top panel, lanes 4 and 6). These results suggest that a complex
of membrane-bound Syk with pp37 may localize with CD34
and CD43 at the plasma membrane.
Fig 4. Capping of CD34 and CD43. KG1a cells were stimulated for
30 minutes with MOPC21 (control, a through c, p through r), anti-
CD34 (My10, d through f; 4A1, g through i; QBEND10, j through l;
8G12, m through o), or anti-CD43 (MEM59, s through u) as described
in the legend to Fig1. After fixation, cells were double-stained with
anti-CD34 (green channel: a, d, g, j, and m) and phalloidin (red
channel: b, e, h, k, and n) or with anti-CD43 (green channel: p and s)
and phalloidin (red channel: q and t), and analyzed by confocal
immunofluorescence microscopy. The right-hand panels show super-
imposed images of green and red channels. Bars, 5 mm.
Fig 5. Capping of CD34full and CD34trunc. U937 cells stably trans-
fected with vector (a through f), CD34full (g through l), or CD34trunc (m
through r) were stimulated for 30 minutes with anti-CD34 (4A1) (d
through f, j through l, p through r) or MOPC21 (control) (a through c, g
through i, m through o). After fixation, cells were double-stained with
anti-CD34 (green channel: a, d, g, j, m, and p) and phalloidin (red
channel: b, e, h, k, n, and q), and analyzed by confocal immunofluores-
cence microscopy. The right-hand panels show superimposed images
of green and red channels. Bars, 5 mm.
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tion. To further dissect the signaling pathway, we examined
the effects of inhibitors on anti-CD34– or anti-CD43–induced
cap formation and tyrosine phosphorylation. As shown in Fig
11A(see page 3730), treatment of KG1a cells with cytochalasin
D (Cyt.D), an inhibitor of actin polymerization, or with NaF, an
adenosine triphosphate (ATP)-depleting agent, blocked both
anti-CD34– and anti-CD43–induced cap formation. We found
that treatment with Cyt.D speciﬁcally inhibited an increase in
tyrosine phosphorylation of Syk and pp77 upon stimulation
with anti-CD34 or anti-CD43 (Fig 11B [see page 3731],
compare lanes 2 and 5 with lanes 1 and 4). Incubation with NaF
blocked an increase in tyrosine phosphorylation of cellular
proteins including Lyn, pp60, pp69, Syk, and pp77 (lanes 3 and
6). Moreover, we observed that not only anti-CD34 but also
anti-CD43 induced homotypic cell aggregation of KG1a cells
(Fig 11C [see page 3731], a and d), and that treatment with
either Cyt.D or NaF completely inhibited antibody-induced
homotypic cell aggregation (b, c, e, and f). These data are
consistentwithrecentobservationsthathomotypiccellaggrega-
tion induced by anti-CD34 requires cellular ATP, a functional
cytoskeleton, and protein-tyrosine kinase activity.13,15 Thus,
these results suggest that cap formation of CD34 or CD43
increases tyrosine phosphorylation of Syk and pp77 through
Lyn, pp60, and pp69 during induction of cytoadhesion.
DISCUSSION
In this study, we provide evidence that the sialomucins CD34
and CD43 can activate a common signaling pathway through
tyrosine phosphorylation in cytoadhesion. First, a stable cap/
cluster of CD34 or CD43, which colocalizes with reorganized
F-actin, is rapidly formed after antibody-mediated crosslinking
of the respective molecules. Second, formation of caps triggers
tyrosine phosphorylation of cellular proteins at each capping
site. Third, tyrosine phosphorylation of the same set of proteins,
such as Lyn, Syk, and the novel proteins pp60, pp69, and pp77,
is speciﬁcally induced by crosslinking of CD34 or CD43.
Fourth, blockade of cap formation by treatment with Cyt.D
leads to inhibition of tyrosine phosphorylation of Syk and pp77
and homotypic cytoadhesion.
In Fig 12, we present a model to account for these ﬁndings.
Crosslinking of CD34 or CD43 with the appropriate antibody
Fig 6. Capping/clustering of CD34 or CD43 on normal CD341 cells.
Normal CD341 BM cells were stimulated with anti-CD34 (4A1) for 0
minutes (a through c) and 30 minutes (d through f), or with anti-CD43
(MEM59) for 0 minutes (g through i) and 30 minutes (j through l). After
fixation, cells were double-stained with anti-CD34 (green channel: a
and d) and phalloidin (red channel: b and e) or with anti-CD43 (green
channel: g and j) and phalloidin (red channel: h and k), and analyzed
by confocal immunofluorescence microscopy. The right-hand panels
show superimposed images of green and red channels. Bar, 5 mm.
Fig 7. Crosslinking of various cell-surface molecules by MoAbs.
(A) Western blot of Triton X-100 lysates of KG1a cells stimulated for
30 minutes with anti-CD34 (4A1), anti-CD11a, anti-CD18, anti-CD49d,
anti-CD49e, or anti-CD54 as described in the legend to Fig1. Molecular
size markers are indicated on the left (kD). (B) Distribution of
adhesion molecules on KG1a cells stimulated as described above.
After fixation, cells were double-stained with FITC–anti-mouse Ig
(green channel: b, f, j, n, and r) and phalloidin (red channel: c, g, k, o,
and s), and analyzed by Nomarski differential-interference-contrast
(left-hand panels) and confocal immunofluorescence microscopy. The
right-hand panels show superimposed images of green and red
channels. Bars, 10 mm.
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and pp69, thereby leading to cell polarization, such as capping,
clustering, and uropod formation. Subsequently, cell polariza-
tion initiates another increase in tyrosine phosphorylation of
Syk and pp77 for homotypic cell aggregation. Although NaF
inhibits the signaling pathway from the initial phase, Cyt.D
blocks an increase in tyrosine phosphorylation induced by cell
polarization, resulting in inhibition of homotypic cell aggrega-
tion. Thus, we propose that cell polarization characterized as
cap formation is crucial for the signal transduction pathway in
CD34- or CD43-mediated cytoadhesion.
In accordance with the previous ﬁndings,13 we showed that
only class I and class II MoAbs directed against CD34, but not
class III MoAbs, induce homotypic cytoadhesion of KG1a cells
(Fig 11C, data not shown), and we found that those antibodies
also induce homotypic cytoadhesion of U937 cells ectopically
expressing CD34full or CD34trunc (data not shown). Similarly,
crosslinking of CD43 on KG1a cells with anti-CD43, which
corresponds to class I anti-CD34 MoAbs, induces homotypic
cytoadhesion (Fig 11C). The stimulatory MoAbs may act as
surrogate ligands mimicking the binding of natural ligands or
counter-receptors by interacting with glycosylated regions of
CD34 or CD43, as suggested.13,15
It is worth noting that addition of greater than 0.1 mmol/L
Na3VO4, an inhibitor of tyrosine phosphatases, to cell suspen-
sions throughout stimulation periods is required to detect an
increase in tyrosine phosphorylation of cellular proteins (Figs 1
through 3, 7, and 9 through 11), suggesting that the increase in
tyrosine phosphorylation seen following crosslinking may be
rapidly downregulated by dephosphorylation. The level of
increase in tyrosine phosphorylation follows the extent of cap
formation, indicating that capping triggers tyrosine phosphory-
lation.
Like CD34full, the alternatively spliced CD34trunc having 16
amino acid residues within the cytoplasmic region is capable of
increasing tyrosine phosphorylation of the same set of proteins
(Fig 2). Delay in myeloid differentiation of embryonic stem
cells with CD34 null mutation was efficiently rescued by
overexpression of either CD34trunc or CD34full.39 CD34 has one
potential phosphorylation site for tyrosine kinases in the
cytoplasmic region (Fig 2A). However, crosslinking of CD34
did not induce tyrosine phosphorylation of CD34 per se (data
not shown). In addition, because CD34trunc lacks consensus
phosphorylation sites for protein kinase C, phosphorylation by
protein kinase C40 is unlikely to be involved in the CD34-
mediated signaling. Furthermore, the truncated CD34 mutant
having only one amino acid residue within the cytoplasmic
region did not trigger CD34 MoAb-induced homotypic cell
aggregation.15 These results indicate that the short cytoplasmic
tail of CD34trunc, but not possible phosphorylation sites found in
the cytoplasmic region of CD34full, is required for crosslinking-
dependent signal transduction.
Fig 8. Localization of phosphotyrosine in KG1a cells after stimula-
tion. KG1a cells were stimulated for 30 minutes with anti-CD34 (4A1),
anti-CD43 (MEM59), or MOPC21 (control) as described in the legend
to Fig 1. After fixation and permeabilization, cells were double-
stained with anti-pTyr (green channel: b, f, and j) and phalloidin (red
channel: c, g, and k), and analyzed by Nomarski differential-
interference-contrast (left-hand panels) and confocal immunofluores-
cence microscopy. The right-hand panels show superimposed images
of green and red channels. Bars, 5 mm.
Fig 11. (A) Inhibition of antibody-induced cap formation. (A)
Distribution of CD34 or CD43 on KG1a cells stimulated for 30 minutes
with anti-CD34 (4A1, a through l) or anti-CD43 (MEM59, m through x)
in the presence of medium alone (a through d, m through p), Cyt.D (e
through h, q through t), or NaF (i through l, u through x) as described
in Materials and Methods. After fixation, cells were double-stained
either with anti-CD34 (green channel: b, f, and j) and phalloidin (red
channel: c, g, and k) or with anti-CD43 (green channel: n, r, and v) and
phalloidin (red channel: o, s, and w), and then analyzed by Nomarski
differential-interference-contrast (left-hand panels) and confocal immu-
nofluorescence microscopy. The right-hand panels show superim-
posed images of green and red channels. Bars, 10 mm.
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tested, only anti-CD34 and anti-CD43 can induce an increase in
tyrosine phosphorylation of the same set of proteins (Figs 3 and
7). These observations indicate that CD34 and CD43 share
some overlapping functions. Although CD34, a member of the
sialomucin family, has no signiﬁcant sequence homology to
known proteins, the heavily O-glycosylated extracellular region
of CD34 is similar to that of CD43, which has an extended
rodlike structure.7,12,19,24 Stimulation with anti-CD34 MoAb
triggers cell adhesion of CD34-expressing hematopoietic
cells.13-15 In addition, stimulation with anti-CD43 MoAb is
reported to induce capping of CD43 and activation of cell-type
speciﬁc functions in different hematopoietic cells, such as T
lymphocytes, neutrophils, and monocytes. These functions
include cell polarization, cell adhesion, proliferation, costimula-
tion, Ca21 mobilization, factor production, and apoptosis.20,41-48
Furthermore, there is increasing evidence that CD43 regulates
tyrosine phosphorylation of cellular proteins in T-lymphocyte
activation, although neither CD43 nor CD34 possesses any
tyrosine kinase structures.20,21,49,50
Given that CD34 and CD43 share some amino acid sequence
identity clusters in the transmembrane domain and the cytoplas-
mic region near the transmembrane domain, it is possible that a
common signal transducer could associate or interact with both
Fig 11. (Cont’d). (B) Anti-pTyr
Western blot of equal amounts
ofTritonX-100lysatesfromKG1a
cells stimulated with anti-CD34
(lanes 1 through 3) or anti-CD43
(lanes 4 through 6) in the pres-
ence of medium alone (lanes 1
and 4), 10 mg/mL cytochalasin D
(Cyt.D) (lanes 2 and 5), or 30
mmol/L NaF (lanes 3 and 6) as
described above. Molecular size
markers are indicated on the left
(kD). (C) Homotypic cytoadhe-
sion of KG1a cells stimulated for
90 minutes with anti-CD34 (a
through c), anti-CD43 (d through
f), or control antibody (g through
i) in the presence of medium
alone (a, d, and g), 10 mg/mL
Cyt.D (b, e, and h), or 30 mmol/L
NaF (c, f, and i). Bars, 80 mm.
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activating tyrosine phosphorylation. Crosslinking of CD34 or
CD43 slightly increased autophosphorylation of Lyn (Figs 1
through 3, 7, and 9 through 11) and led to localization of Lyn to
the capping site (data not shown). However, an increase in Lyn
kinase activity was barely detected in in vitro kinase assays, and
basal activity of Lyn kinase was detected at high levels (data not
shown). We hypothesize that activation of a tyrosine kinase(s)
takes place through a common signal transducer at the capping
site after F-actin reorganization, and the resulting tyrosine-
Fig 9. Characterization of tyrosine-phosphorylated proteins. (A
and B) Western blots of Lyn and Syk immunoprecipitated with
anti-Lyn (A) or anti-Syk (B) from Triton X-100 lysates of KG1a cells
stimulated for 30 minutes with MOPC21 (control, lane 1), 4A1 (lane 2),
or MEM59 (lane 3) as described in the legend to Fig 1, probed with
anti-pTyr (top panels), and reprobed with anti-Lyn (A, bottom panel)
or anti-Syk (B, bottom panel). IgG (H), heavy chain of immunoglobulin
G. (C) (Top two panels) Western blots of modified RIPA-washed Syk
immunoprecipitates from Triton X-100 lysates prepared as described
above, probed with anti-pTyr, and reprobed with anti-Syk. (Bottom
two panels) Autoradiograms of in vitro phosphorylation of Syk and
MBP by aliquots of the modified RIPA-washed Syk immunoprecipi-
tates. Syk kinase activities were determined by measuring the
incorporation of 32PO4 into Syk per se and MBP and expressed as
values relative to the specific activity of Syk in the control sample
(lane 1).
Fig 10. Subcellular localization of tyrosine-phosphorylated pro-
teins. (A) Western blots of cytosolic (S100, lanes 1, 3, and 5) and
particulate fractions (P100, lanes 2, 4, and 6) fractionated from KG1a
cells stimulated for 30 minutes with MOPC21 (control, lanes 1 and 2),
anti-CD34 (4A1, lanes 3 and 4) or anti-CD43 (MEM59, lanes 5 and 6) as
described in the legend to Fig 1, probed with anti-pTyr (top), reprobed
with anti-CD34 (4A1), anti-CD43 (MEM59), anti-Syk, and anti-Lyn.
Molecular size markers are indicated on the left (kD). (B) Western
blots of equally adjusted amounts of Syk immunoprecipitates from
cytosolic (S100, lanes 1, 3, and 5) or Triton X-100–solubilized mem-
brane fractions (P100, lanes 2, 4, and 6) of KG1a cells stimulated as
above, probed with anti-pTyr (top), and reprobed with anti-Syk
(bottom). IgG (H), heavy chain of immunoglobulin G.
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Lyn to transmit the signals downstream. Alternatively, high
levels of basal Lyn kinase activity might be involved in complex
formation of pp69 and pp77 with Lyn after stimulation. In
addition, another possibility is that activation of a tyrosine
kinase(s) may lead to tyrosine phosphorylation of unphosphory-
lated pp69 and pp77 that already appear to be associated with
Lyn.
Moreover, while crosslinking of CD34 or CD43 increased
tyrosine phosphorylation of Syk, an increase in Syk kinase
activity was not detected (Fig 9B and C). Rather, we found an
increase in tyrosine phosphorylation of pp37 associated with
tyrosine-phosphorylated Syk localized to the membrane (Figs
9B and 10B). These data suggest that tyrosine phosphorylation
of Syk creates docking sites for proteins that possess the Src
homologous 2 (SH2) domains, as suggested recently.51,52 Alter-
natively, it is also possible that cytoplasmic Syk is associated
with unphosphorylated pp37.After stimulation, complexes with
tyrosine-phosphorylated Syk and pp37 may be anchored to
membranes. However, the latter possibility is unfavorable
because cytoplasmic Syk is not translocated to the membrane
(Fig 10A).Therefore, it is intriguing to assume that crosslinking
either CD34 or CD43 promotes cooperation between Syk and
Lyn, through an as yet unknown mechanism. Identiﬁcation of
pp37, pp69, and pp77 will help us more fully understand
signaling initiated by activation of CD34 and CD43.
For several years there has been high interest in capping of
cell-surface receptors.53,54 It should be emphasized that caps of
CD34 or CD43 are quite stable and continue to be present on the
cell surface for at least 2 days after stimulation, whereas other
cell-surface molecules such as B-cell antigen receptors, T-cell
antigen receptors, low-density lipoprotein receptors, transferrin
receptors, and integrins are rapidly internalized/endocytosed
from the cell surface for degradation or recycling upon stimula-
tion. Thus, CD34 and CD43 caps are envisaged as unique
features toward signal transduction. Recently, cell polarization
and clustering of CD43 to a cellular uropod have been seen in T
lymphocytes stimulated with anti-CD43.47 Similar clustering of
CD43 on neutrophils was observed during neutrophil chemo-
taxis after stimulation with either chemokine peptides alone or
with anti-CD43 antibodies.48 CD43 expressed on T lympho-
cytes was associated with the ERM actin-binding proteins ezrin
and moesin at the capping site after stimulation for cell
aggregation and migration.55 These observations suggest that
cell polarization leads to cytoadhesion and cell motility.
Although the physiological function of CD34 is still unclear,
perhaps cell polarization via clustering of CD34, like CD43,
plays a role in cell motility. One could therefore add a pathway
for cell motility in Fig 12. Considering our ﬁndings that CD34
and CD43 can trigger tyrosine phosphorylation through cap
formation, we imagine that cell polarization induced by capping
of CD34 or CD43 leads to close localization of tyrosine-
phosphorylated proteins including Lyn and Syk with CD34 or
CD43, and actively participates in signal transduction generated
from the capping sites for cytoadhesion and cell motility.
Finally, CD34 and CD43 are expressed on hematopoietic
stem cells.23,25,26 KG1a cells, which express both CD34 and
CD43, have many characteristics of immature hematopoietic
cells.3,27 Like KG1a cells, CD131 CD341 CD431 peripheral
mononuclear cells from a myelogenous leukemic patient exhib-
ited cap formation of CD34 or CD43 after stimulation with
respective antibodies (data not shown). Intriguingly, normal
CD341 CD431 cells from normal human BM cells became
polarized after crosslinking of CD34 or CD43 (Fig 6). There-
fore, it will be necessary to investigate the physiological roles of
CD34 and CD43 on immature hematopoietic cells in BM stem
cell niches.
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